 |
Talee Bio
Last updated: September 27, 2025
Joan Lau, CEO
Germany | Funding: $4.7M (+)
Website: http://spirovant.com/
Our mission at Talee Bio is to change the course of cystic fibrosis and other genetic lung diseases by developing novel genetic treatments. Our gene therapy technologies are designed to overcome the barriers that have so far prevented effective genetic treatments for cystic fibrosis.
Website: http://spirovant.com/
Our mission at Talee Bio is to change the course of cystic fibrosis and other genetic lung diseases by developing novel genetic treatments. Our gene therapy technologies are designed to overcome the barriers that have so far prevented effective genetic treatments for cystic fibrosis.
